Pharmaceutical emulsions: a new approach for gene therapy

被引:21
作者
Verissimo, Lourena Mafra [1 ]
Agnez Lima, Lucymara Fassarela [2 ]
Monte Egito, Lucila Carmem [2 ]
de Oliveira, Anselmo Gomes [3 ]
Tabosa do Egito, E. Socrates [1 ]
机构
[1] Univ Fed Rio Grande do Norte, LASID, BR-59072970 Natal, RN, Brazil
[2] Univ Fed Rio Grande do Norte, Dept Biol Celular & Genet, LBMG, Ctr Biociencias, Natal, RN, Brazil
[3] UNESP, Fac Ciencias Farmaceut, Dept Farm & Medicamentos, Araraquara, SP, Brazil
关键词
Cationic emulsions; gene transfection; gene therapy; carrier systems; delivery systems; SMALL INTERFERING RNA; LIPID-BASED EMULSION; IN-VITRO; CATIONIC EMULSION; NONIONIC SURFACTANTS; IMMUNE-RESPONSES; NONVIRAL VECTORS; CARRIER SYSTEMS; DRUG-DELIVERY; NUCLEIC-ACIDS;
D O I
10.3109/10611860903434019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The concept of gene therapy involves the experimental transfer of a therapeutic gene into an individual's cells and tissues to replace an abnormal gene aiming to treat a disease, or to use the gene to treat a disease just like a medicine, improving the clinical status of a patient. The achievement of a foreigner nucleic acid into a population of cells requires its transfer to the target. Therefore, it is essential to create carriers (vectors) that transfer and protect the nucleic acid until it reaches the target. The obvious disadvantages of the use of viral vectors have directed the research for the development of a nonviral organized system such as emulsions. In fact, recently, there has been an increase of interest in its use in biotechnology as a nonviral vector for gene therapy. This review focuses on the progress of cationic emulsions and the improvement of the formulations, as a potential delivery system for gene therapy.</.
引用
收藏
页码:333 / 342
页数:10
相关论文
共 93 条
[1]   INVESTIGATIONS INTO THE FORMATION AND CHARACTERIZATION OF PHOSPHOLIPID MICROEMULSIONS .1. PSEUDO-TERNARY PHASE-DIAGRAMS OF SYSTEMS CONTAINING WATER-LECITHIN-ALCOHOL-ISOPROPYL MYRISTATE [J].
ABOOFAZELI, R ;
LAWRENCE, MJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 93 (1-3) :161-175
[2]  
ARDOIN N, 1995, B SOC CHIM FR, V132, P875
[3]   Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus [J].
Armelini, MG ;
Muotri, AR ;
Marchetto, MCN ;
de Lima-Bessa, KM ;
Sarasin, A ;
Menck, CFM .
CANCER GENE THERAPY, 2005, 12 (04) :389-396
[4]  
Barut KD, 2005, TURK J CHEM, V29, P27
[5]  
Becher P., 1965, Emulsions: Theory and Practice
[6]   Good news for gene therapy [J].
Berns, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (16) :1679-1680
[7]   Immune responses to gene therapy vectors: influence on vector function and effector mechanisms [J].
Bessis, N ;
GarciaCozar, FJ ;
Boissier, MC .
GENE THERAPY, 2004, 11 (Suppl 1) :S10-S17
[8]   PEGylated lipoplexes: Preparation Protocols affecting DNA condensation and cell Transfection efficiency [J].
Bombelli, Cecilia ;
Faggioli, Francesca ;
Luciani, Paola ;
Mancini, Giovanna ;
Sacco, Maria Grazia .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (24) :6274-6278
[9]   Gene delivery with synthetic (non viral) carriers [J].
Brown, MD ;
Schätzlein, AG ;
Uchegbu, IF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 229 (1-2) :1-21
[10]   Gene therapy for inborn errors of liver metabolism [J].
Brunetti-Pierri, N ;
Lee, B .
MOLECULAR GENETICS AND METABOLISM, 2005, 86 (1-2) :13-24